05 Feb, EOD - Indian

SENSEX 78271.28 (-0.40)

Nifty 50 23696.3 (-0.18)

Nifty Bank 50343.05 (0.37)

Nifty IT 42888.3 (0.07)

Nifty Midcap 100 54180.85 (0.68)

Nifty Next 50 64012.8 (0.65)

Nifty Pharma 21868.5 (0.62)

Nifty Smallcap 100 17108.5 (1.85)

05 Feb, EOD - Global

NIKKEI 225 38831.48 (0.09)

HANG SENG 20597.09 (-0.93)

S&P 6099 (0.40)

LOGIN HERE

companylogoLupin Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 500257 | NSE Symbol : LUPIN | ISIN : INE326A01037 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
22-Oct-2024 07-Nov-2024 Quarterly Results Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2024 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024. Read less.. (As Per BSE Announcement Dated on 22.10.2024) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024. (As Per BSE Announcement Dated on: 07/11/2024)
23-Jul-2024 06-Aug-2024 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2024 and other business matters.
22-Apr-2024 06-May-2024 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 ,inter alia, to consider and approve audited financial results of the Company for the quarter and year-ended March 31, 2024 and recommend dividend, if any. Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31, 2024 And Recommend Final Dividend @ 400% i.e. Rs. 8/- Per Equity Share Of The Face Value of Rs. 2/- Each For The Year Ended March 31, 2024. Appointment of Mr. Jeffrey Kindler and Mr. Alfonso Zulueta as Independent Directors of the Company effective May 6, 2024. (As Per BSE Announcement Dated on: 06/05/2024)
22-Mar-2024 22-Mar-2024 Others The Company plans to carve out, its trade generics business in India, as a going concern, on a slump sale basis, to Lupin Life Sciences Limited, wholly owned subsidiary of the Company.
24-Jan-2024 07-Feb-2024 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine-months ended December 31 2023. Unaudited Financial Results for the quarter and nine-months ended December 31, 2023. (As per BSE Announcement Dated on 07/02/2024)
25-Oct-2023 08-Nov-2023 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the unaudited financial results of the Company for the quarter and half-year ended September 30 2023 and other business matters. Unaudited Financial Results for the quarter and half-year ended September 30, 2023. (As per BSE Announcement Dated on 08/11/2023)
21-Jul-2023 03-Aug-2023 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2023 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2023 and other business matters. LUPIN LIMITED has informed BSE about Board Meeting to be held on 03 Aug 2023 to consider financial statements for the period ended June 2024. Financial results / Other business. (As Per BSE Announcement Dated on 22/07/2023)
25-Apr-2023 09-May-2023 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2023 inter alia to consider and approve the audited financial results of the Company for the quarter and year ended March 31 2023 and recommend dividend if any. Audited Results & Final Dividend (As per BSE Bulletin dated on 25/04/2023) Audited Financial Statements for the quarter and year ended March 31, 2023. Approval of the Audited Financial Statements for the quarter and year ended March 31, 2023 and recommend final dividend @ 200% i.e. Rs. 4/- per equity share of the face value of Rs. 2/- each for the year ended March 31, 2023. (As per BSE Announcement Dated on 09/05/2023)
25-Jan-2023 09-Feb-2023 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve unaudited financial results of the Company for the quarter and nine-months ended December 31 2022. Unaudited standalone and consolidated financial results of the Company along with Limited Review Report for the quarter and nine-months ended December 31, 2022. (As Per BSE Announcement Dated on 09/02/2023)
27-Oct-2022 09-Nov-2022 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30 2022 and other business matters. Unaudited standalone and consolidated financial results along with Limited Review Reports for the quarter and half-year ended September 30, 2022. (As Per BSE Announcement Dated on 09/11/2022)
20-Jul-2022 03-Aug-2022 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2022 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2022 and other business matters. Unaudited standalone and consolidated financial results along with Limited Review Reports for the quarter ended June 30, 2022. (As Per BSE Announcement dated on 03.08.2022)
03-May-2022 18-May-2022 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2022 inter alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31 2022 recommend dividend if any and other business matters. Lupin Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2022, inter alia, has recommended dividend @200% i.e.Rs. 4/- per equity share of the face value of Rs. 2/- each for the year ended March 31, 2022, subject to approval of Members at the ensuing Annual General Meeting. The total outflow would be Rs. 1818 million. Audited Financial Statements for the quarter and year ended March 31, 2022. (As Per BSE Announcement Dated on 18.05.2022)
19-Jan-2022 03-Feb-2022 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2022 inter alia to consider and approve LUPIN LTD. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2022inter alia to consider and take on record the unaudited financial results of the Company for the quarter and nine-months ended December 31 2021. Unaudited standalone and consolidated financial results for the quarter and nine-months ended December 31, 2021. (As Per BSE Announcement dated on 03.02.2022)
14-Oct-2021 27-Oct-2021 Quarterly Results Quarterly Results Unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2021. (As Per BSE announcement Dated on 27.10.2021)
30-Jul-2021 10-Aug-2021 Quarterly Results LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2021 and other matters.
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +